Our current primary focus areas are rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) including epithelioid sarcoma, diffuse intrinsic pontine glioma, pediatric high grade glioma, NF1-associated low grade glioma, ETMR, hepatoblastoma, osteosarcoma, Ewing’s sarcoma and medulloblastoma. We address pediatric cancers that occur across all age ranges from children to adolescents, young adults and older adults.
The Pheonix Spangler Foundation is proud to support research at the Children’s Cancer Therapy Development Institute (cc-TDI) in memory of teen Pheonix Spangler. The Pheonix Spangler Foundation announces a substantial research support contribution to the Children’s...read more
The Reser Family Foundation has made a generous contribution to the Children’s Cancer Therapy Development Institute (cc-TDI) in honor of Lakeridge High School student and cancer survivor, Eli Waehrer and other children & adolescents whose lives have been touched by...read more
Please bookmark this page and visit weekly for the latest updates! Rhabdomyosarcoma is a rare cancer of children, adolescents and young adults (and sometimes older adults). There are two major subtypes, alveolar (ARMS) and embryonal (ERMS). Rhabdomyosarcoma is...read more
Sponsored by ... Alexa's Honor Page The goal of The Alexa Project is to find new treatments to move towards clinical trials for all children affected with the neurofibromatosis-1 (NF1) associated brain tumors called juvenile pilocytic astrocytoma (JPA). The Alexa...read more
This 1:1 matching project is detailed here. GEAR...read more
Please bookmark this project and visit weekly for the latest update. This project is inspired by two girls, Macy and Addie, who shared an uncommon brightness in life that leads our team to ask, how can a parent - scientific team bring highly effective treatments to...read more